Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2022 08:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Intention to Issue Shares in Payment of Principal and Interest on Outstanding Debentures

SAINT LAURENT, Quebec, June 01, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces that it intends to (i) issue shares of common...
May 12, 2022 16:05 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reports First Quarter 2022 Financial Results

SAINT LAURENT, Quebec, May 12, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the first quarter...
May 10, 2022 16:05 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Voting Results on Election of Directors and other items

SAINT-LAURENT, Quebec, May 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company”) announces that shareholders voted in favour of all items of business...
May 05, 2022 16:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Report First Quarter 2022 Financial Results on May 12, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, May 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its...
April 26, 2022 16:45 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that management will...
March 24, 2022 16:03 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reports Fourth Quarter and Full-Year 2021 Financial Results

SAINT LAURENT, Quebec, March 24, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the three- and...
March 17, 2022 16:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, March 17, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release...
February 01, 2022 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Receives Third Loan Tranche from atai

SAINT LAURENT, Quebec, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Further to its press release dated September 15, 2021, IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company”) today announced that its...
January 20, 2022 08:00 ET | Source: IntelGenx Technologies Corp.

First Patient Dosed in IntelGenx’s Resumed ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease

SAINT LAURENT, Quebec, Jan. 20, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”), a leader in pharmaceutical films, today announced that patient dosing...
December 08, 2021 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Initiates Arbitration Proceeding Against Tilray® Related to an Alleged Breach of Worldwide Cannabis-Infused VersaFilm® Agreement

SAINT LAURENT, Quebec, Dec. 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has initiated an arbitration proceeding against...